Citalopram controlled release - Lundbeck A/S/Valeant Pharmaceuticals International
Latest Information Update: 21 Sep 2015
At a glance
- Originator Lundbeck A/S
- Developer Lundbeck A/S; Valeant Pharmaceuticals International
- Class Antidepressants; Benzofurans; Nitriles; Propylamines; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Depressive disorders
Most Recent Events
- 15 Mar 2016 Biomarkers information updated